In vitro studies have shown that morphine can promote the proliferation of cervical cancer cells by activating the opioid receptor-dependent EGFR-mediated signaling pathway and stimulate migration by activating the opioid receptor-independent RhoA-mediated signaling pathway (Yu et al., 2022). The gene discussed is RHOA; the disease is cervical carcinoma.